About Babatunde Otulana
Form D filings for Flow Pharma from 2022 to 2024 list Babatunde Otulana as director.
Babatunde Otulana first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Babatunde Otulana in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Babatunde Otulana works with at each company, as listed on that company's latest Form D.
Flow Pharma, Inc. · Form D/A, Aug 8, 2024
PS
Pamela Steele
Director
AT
Anthony Tufaro
Director
RR
Reid Rubsamen
Chief Executive Officer and director
TB
Tikoes Blankenberg
Director